IMol

Join Dr. Nicola De Franceschi’s Group as a postdoctoral researcher to work on a highly innovative project funded by NCN Narodowe Centrum Nauki Opus-29 grant, exploring how proto-metabolism may have emerged at the origin of life, using a bottom-up approach to generate membrane potential and drive (bio)chemical reactions.

Starting May 1, 2026 (or as soon as possible).

To apply, please submit your documents via the application form: https://euraxess.ec.europa.eu/jobs/400762

💡Today in Warsaw we are concluding our scientific week with the conference “Science. Patients. Therapies.”, where Prof. Victor Ambros, 2024 Nobel Prize Laureate in Physiology or Medicine and discoverer of microRNA - is delivering a special lecture on how RNA biology is shaping the future of precision medicine and rare disease therapies.

The event was initiated by Dr. Aldona Chmielewska (AGO Alliance Poland), who has turned scientific expertise toward finding a treatment for her son diagnosed with the ultra-rare AGO syndrome. In collaboration with families, clinicians, and researchers - and with the support of the IMol and Warszawski Uniwersytet Medyczny - WUM - she brought the scientific and patient communities around a shared goal. We deeply admire her dedication and courage in turning personal challenges into hope for others.

The program also features a talk by Prof. Maciej Ciesla from IMol, presenting our institute’s research and how our work in RNA biology contributes to advancing new therapeutic strategies.

At IMol, we are proud to support initiatives that connect world-class science with real patient needs. Welcoming internationally recognized scientists such as Prof. Victor Ambros to Warsaw reflects our commitment to building global collaborations that accelerate research and bring new therapeutic opportunities closer to patients. 🌍

Special thanks to the IMol Organizing Committee: Prof. Agnieszka Chacińska, Prof. Maciej Ciesla and Zofia Majkowska!